Pharmaceutical Sciences

ramachandran
  • Graduate Student / Research Assistant
Lab Phone: 806-414-9223
E-Mail: sharavan.ramachandran@ttuhsc.edu
Mail Address: 1406 S Coulter
Amarillo, TX 79106-1786

Biography

Sharavan Ramachandran completed his Bachelor of Technology in Biotechnology degree at Kalasalingam University, Tamil Nadu, India, in 2012, and his Master of Science degree in Biotechnology from Nottingham Trent University, UK, in 2014. He joined the Graduate Program in Pharmaceutical Sciences as a PhD student in Fall of 2015, and is presently working in the laboratory of Dr. Sanjay Srivastava with the Department of Pharmaceutical Sciences.

Education:

  • MS: Biotechnology, Nottingham Trent University, UK, 2014
  • BS: Biotechnology, Kalasalingam University, Tamil Nadu, India, 2012

Research Interests:

Identification of potential therapeutic targets for cancer; Elucidating the mechanisms involved in cancer progression and developing anti-cancer agents to counteract the progression; Screening novel compounds for cancer therapy at key stages of cancer progression; Study of the anti-cancer agents in in-vivo models and examine the mechanism involved in the inhibition of cancer growth.

Publications:

   Before Admission to GPPS:

  • Danda R, Ganapathy K, Sathe G, Madugundu AK, Ramachandran S, Krishnan UM, Khetan V, Rishi P, Keshava Prasad TS, Pandey A, Krishnakumar S, Gowda H, Elchuri SV. Proteomic profiling of retinoblastoma by high resolution mass spectrometry. Clin Proteomics. 2016 Oct 26;13:29. eCollection 2016.
  • Deepak V, Ramachandran S, Balahmar RM, Pandian SR, Sivasubramaniam SD, Nellaiah H, Sundar K. In vitro evaluation of anticancer properties of exopolysaccharides from Lactobacillus acidophilus in colon cancer cell lines. In Vitro Cell Dev Biol Anim. 2016 Feb;52(2):163-73. Epub 2015 Dec 10.
  • Venkataraman Deepak , Ramachandran Sharavan, Sureshbabu Ram Kumar Pandian, Reham,  Shiva D.Sivasubramaniam, Hariharan Nellaiah and Krishnan Sundar. In Vitro Cell Dev Biol Anim. 2016 Feb;52(2):163-73. Epub 2015 Dec 10.

   After Admission to GPPS:

  • Kim CG, Lee H, Gupta N, Ramachandran S, Kaushik I, Srivastava S, Kim SH, Srivastava SK. Role of Forkhead Box Class O proteins in cancer progression and metastasis. Semin Cancer Biol. 2017 Aug 1. pii: S1044-579X(17)30092-5. [Epub ahead of print]

Presentations:

   Before Admission to GPPS:

  • Sivasubramaniam D. Shiva, Ramachandran Sharavan. “New breed of ghost writers: Emerging threats to academic community via internationalization and social media”. Annual Conference on Plagiarism Research, Czech Republic, Referred conference paper, 2015.
  • Sharavan Ramachandran. "PNA - technology". International Conference on Computational Biology and Nanotechnology (ICCBN-2010), Vivekananda College of Engineering for Women, Tiruchengode, Referred conference paper, 2010.

   After Admission to GPPS:

  • Sharavan Ramachandran and Sanjay K. Srivastava. "Novel Anti-Parkinson Drug for Pancreatic Cancer Treatment". Seventeenth Annual Research Days, TTUHSC School of Pharmacy Amarillo, TX; June 2018.
  • Sharavan Ramachandran and Sanjay K. Srivastava. "Novel antipsychotic drug for pancreatic cancer treatment". American Association for Cancer Research, Chicago, IL; April 2018.
  • Sharavan Ramachandran, Neel Fofaria and Sanjay K. Srivastava. "Piperlongumine, a novel option to overcome BRAF inhibitor resistance in melanoma". American Association for Cancer Research, Chicago, IL; April 2018.
  • Sharavan Ramachandran and Sanjay K Srivastava. "Capsaicin: a negative regulator of Warburg effect in pancreatic cancer". Society of Toxicology, San Antonio, TX; March 2018.
  • Sharavan Ramachandran & Sanjay K. Srivastava. "Capsaicin negatively regulated Warburg effect in pancreatic cancer and enhances the effects of gemcitabine". Symposia on Cancer Research, MD Anderson Cancer Center, University of Texas, Houston, TX; October 2017.
  • Sharavan Ramachandran and Sanjay K. Srivastava. “Capsaicin suppresses pancreatic tumor growth by inhibiting tumor metabolism and enhances the effect of gemcitabine”. Sixteenth Annual Research Days, TTUHSC School of Pharmacy, Amarillo TX; June 2017.
  • Sharavan Ramachandran and Sanjay K. Srivastava. "Capsaicin: A negative regulator of the Warburg effect in pancreatic cancer". American Association of Pharmaceutical Scientists (AAPS), National Biotechnology Conference (NBC), San Diego, CA; May 2017.
  • Sharavan Ramachandran and Sanjay K. Srivastava. "Capsaicin suppresses pancreatic tumor growth by inhibiting tumor cell metabolism." American Association for Cancer Research, Washington, D.C.; April 2017.
  • Sharavan Ramachandran and Sanjay K. Srivastava. "Capsaicin suppresses pancreatic tumor growth by inhibiting tumor cell metabolism". Student Research Week, TTUHSC Graduate School of Biomedical Sciences, Lubbock, TX; March 2017.
  • Sharavan Ramachandran, Neel Fofaria and Sanjay K. Srivastava. "Novel Propanoic acid derivative sensitize BRAF mutated melanoma cells and overcome resistance to Vemurafenib therapy". American Association of Pharmaceutical Scientists, Denver, CO; November 2016.
  • Sharavan Ramachandran, Neel Fofaria and Sanjay K. Srivastava. "Novel Propanoic acid derivative sensitize BRAF mutated melanoma cells and overcome resistance to Vemurafenib therapy". Lone Star Regional Chapter, Society of Toxicology (LSSOT), Waco, TX; October 2016.
  • Sharavan Ramachandran, Neel Fofaria, Sanjay K. Srivastava. “Novel Propanoic Acid Derivative Sensitizes Braf Mutated Melanoma Cells.” Fifteenth Annual Research Days, TTUHSC School of Pharmacy, Amarillo, TX; June 2016.

Seminars:

  • 04/04/2018 "Anti-Psychotic Drug for Pancreatic Cancer Treatment"
  • 09/13/2017 "Piperlongumine: A novel treatment option to overcome chemoresistance in melanoma" [Oral Qualifying Exam public presentation, counted as Seminar credit]
  • 03/01/2017 "Capsaicin: A Negative Regulator of the Warburg Effect in Pancreatic Cancer"

Awards/Scholarships:

   Before Admission to GPPS:

  • Nottingham Trent University International Scholarship, 2013-2014.

   After Admission to GPPS:

  • Seahorse Travel Award, Agilent Technologies, American Association for Cancer Research, Chicago, IL; April 2018.
  • Travel Grant, Cayman Chemical, American Association for Cancer Research, Chicago, IL; April 2018.
  • Syngenta Fellowship Grant in Human Health Applications of New Technologies, to be presented at SOT Annual Meeting & ToxExpo, San Antonio, TX; March 2018.
  • Young Investigator Travel Fellowship Award, Symposia on Cancer Research 2017: Cancer Metabolism; MD Anderson Cancer Center, University of Texas, Houston, TX; October 2017.
  • TTUHSC GSBS Mary Lou Clements-Mann Scholarship, Fall 2017.
  • Amgen Travelship, American Association of Pharmaceutical Scientists (AAPS), National Biotechnology Conference (NBC), San Diego, CA; May 2017.
  • Seahorse Bioscience Travel Award from Agilent Technologies, American Association for Cancer Research, Washington, D.C.; April 2017.

Memberships:

  • Graduate Student Association in Amarillo – International Representative, 2017-2018.
  • Graduate Student Association at Amarillo, 2015-present.
  • Indian Society of Technical Education, 2008-present.
Placeholder image

Give

Optional subheading text

View more
Placeholder image

Give

Optional subheading text

View more

Got Questions?

We're hear to help. Contact us if you have questions.

John Doe

(555) 555 - 5555

john.doe@email.edu

example image

Spotlight Example Header

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.